Floatz logo

45 assets in T Lymphoblastic Leukemia/Lymphoma

Therapeutic assets addressing T Lymphoblastic Leukemia/Lymphoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cyclophosphamide
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3BB (66)
Cytarabine
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP3BB (66)
Prednisone
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3BB (66)
Etoposide
T Lymphoblastic Leukemia/Lymphoma
Children's Cancer Group, ChinaP3BB (64)
Adriamycin
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3B (62)
Daunomycin
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3B (62)
Decitabine
T Lymphoblastic Leukemia/Lymphoma
M.D. Anderson Cancer CenterP3B (62)
Dexasone
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3B (62)
Mercaptopurine Anhydrous
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3B (62)
Venetoclax
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP2/3B (62)
Vincristine Sulfate
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3B (62)
Bortezomib
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3B (60)
Busulfanum
T Lymphoblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang UniversityP2B (60)
Calaspargase Pegol
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3B (60)
Isocyclophosphamide
T Lymphoblastic Leukemia/Lymphoma
Children's Cancer Group, ChinaP3B (60)
(+)-Vincristine
T Lymphoblastic Leukemia/Lymphoma
Children's Cancer Group, ChinaP3B (60)
Vindesine
T Lymphoblastic Leukemia/Lymphoma
Children's Cancer Group, ChinaP3B (60)
Fludarabine
T Lymphoblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang UniversityP2B (59)
her2bbζ/cd19t+ t cells
T Lymphoblastic Leukemia/Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd.P2B (58)
Methotrexate
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP3B (58)
Cephalotaxine 4-Methyl (2R)-2-Hydroxy-2-(4-Hydroxy-4-Methylpentyl)Butanedioate (Ester)
T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP2/3B (57)
Dasatinib
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP2/3B (57)
Tucidinostat
T Lymphoblastic Leukemia/Lymphoma
Zhejiang UniversityP2B (57)
Daratumumab
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Hydrocortisone
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Pegaspargase
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Prednisolone
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Thioguanine Anhydrous
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (55)
Nelarabine
T Lymphoblastic Leukemia/Lymphoma
Children's Oncology GroupP2/3CCC (53)
Thiotepa
T Lymphoblastic Leukemia/Lymphoma
First Affiliated Hospital of Zhejiang UniversityP2CCC (53)
Car.70/Il15-Transduced Cb-Nk Cells
T Lymphoblastic Leukemia/Lymphoma
M.D. Anderson Cancer CenterP1/2CCC (48)
cd7-cart01
T Lymphoblastic Leukemia/Lymphoma
Bambino Gesù Hospital and Research InstituteP1/2CCC (48)
Supcd7 Cart Cells
T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1/2CC (47)
Anti-Cd7 Car-T Cells
T Lymphoblastic Leukemia/Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineP1CC (46)
Capivasertib
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP1/2CC (45)
Navitoclax
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP1/2CC (45)
Ruxolitinib
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP1/2CC (45)
Trametinib
T Lymphoblastic Leukemia/Lymphoma
Princess Maxima Center for Pediatric OncologyP1/2CC (45)
Anti-Cd5 Car Nk Cells
T Lymphoblastic Leukemia/Lymphoma
Chongqing Precision Biotech Co., LtdP1CC (43)
cd19-ucart
T Lymphoblastic Leukemia/Lymphoma
Shenzhen University General HospitalP1CC (43)
Cxcr4 Ccr9 Car-T
T Lymphoblastic Leukemia/Lymphoma
The First Affiliated Hospital of Soochow UniversityP1CC (43)
ucd7 cart
T Lymphoblastic Leukemia/Lymphoma
Institute of Hematology & Blood Diseases Hospital, ChinaP1CC (43)
Autologous Cd7-Targeting Car T Cells
T Lymphoblastic Leukemia/Lymphoma
Hebei Senlang Biotechnology Inc., Ltd.P2NR ()
Beam-201
T Lymphoblastic Leukemia/Lymphoma
Beam Therapeutics Inc.P1/2NR ()